# Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?

> **NCT01252342** · PHASE4 · WITHDRAWN · sponsor: **University of Saskatchewan**

## Conditions studied

- Postpartum Hemorrhage
- Uterine Atony

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01252342
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-08
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Proposed doses were too large, bolus oxytocin may cause cases of arrythmias, and some even advocate slowing down the infusion rates that are currently used.
- **Last updated:** 2012-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252342, "Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01252342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*